Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.

Also called NCT03635190

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 112 participants (enrolled count) (from the registry)
Sponsor
Cardio Flow, Inc. (from the registry)
Registry
  • NCT NCT03635190
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03635190. Allocation not applicable; no masking; primary purpose treatment. Start 2018-12-17 (actual); primary completion 2021-03-24 (actual). Results posted on 2022-11-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
Acronym
FASTII
Condition
Peripheral Arterial Disease
Intervention (Device)
Orbital Circumferential Atherectomy
Lead sponsor
Cardio Flow, Inc. (class: industry)
Collaborator
Libra Medical (class: other)

Record details

Record id
cardio:ct-nct03635190
Content hash
c7412e1df23a459b60955d4c3f6008a8c8949f77025939cefee8adb0eacd5382